![]() | Only 14 pages are availabe for public view |
Abstract Hepatitis B Virus (HBV) infection remains a major global public health problem, despite the availability of a highly effective vaccine and improvements in antiviral therapy. Globally, of the two billion people previously infected, more than 350 million people have developed chronic HBV infection, causing one million HBVrelated deaths each year. HBV infection varies according to geography, with chronic HBV prevalence ranging from0.2% to 20%. Approximately 45% of the world’s population lives in highly endemic areas, such as Africa and the Asia-Pacific region excluding Japan, Australia and New Zealand. Hepatitis C Virus (HCV) is a major cause of liver disease worldwide and a potential cause of substantial morbidity and mortality in the future. The complexity and uncertainty related to the geographic distribution of HCV infection and chronic hepatitis C, determination of its associated risk factors, and evaluation of cofactors that accelerate its progression, underscore the difficulties in global prevention and control of HCV. The aim of this study is to determine the prevalence of Hepatitis B virus surface Antigen (HBsAg) and Hepatitis C Virus Antibodies (HCV Abs) among workers of Zagazig Faculty of medicine and its hospitals and determination of the possible risk factors for prevalence of these health problems. |